InsidersTradesSigma
Discover the detailed record of transactions filed by Walts Alan Edmund, Director. Director active across 1 companies, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. The latest transaction was filed on 1 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Alan Edmund Walts serves as a Director of Eloxx Pharmaceuticals, Inc. As a board member, he contributes to overseeing the company's operations and making strategic decisions. Alan brings expertise in the pharmaceutical sector, which is crucial for the growth and innovation of Eloxx. His commitment to corporate governance is essential for ensuring transparency and accountability.